X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1603) 1603
humans (1199) 1199
antifungal agents - pharmacology (952) 952
microbiology (856) 856
echinocandins (827) 827
pharmacology & pharmacy (646) 646
echinocandins - pharmacology (644) 644
antifungal agents - therapeutic use (640) 640
microbial sensitivity tests (606) 606
lipopeptides (586) 586
caspofungin (573) 573
infectious diseases (514) 514
antifungal agents (469) 469
candida - drug effects (433) 433
fluconazole (431) 431
drug resistance, fungal (426) 426
amphotericin-b (397) 397
echinocandins - therapeutic use (384) 384
male (376) 376
candidiasis - drug therapy (357) 357
micafungin (342) 342
voriconazole (335) 335
female (332) 332
mycology (316) 316
susceptibility (316) 316
bacterial infections and mycoses (310) 310
echinocandin (298) 298
candidiasis - microbiology (296) 296
candida (292) 292
invasive candidiasis (283) 283
resistance (283) 283
animals (275) 275
epidemiology (254) 254
candida albicans - drug effects (243) 243
middle aged (240) 240
mycoses (226) 226
candidiasis (224) 224
adult (220) 220
candida - isolation & purification (220) 220
amphotericin b (213) 213
anidulafungin (210) 210
amphotericin b - pharmacology (207) 207
infections (206) 206
fungi (200) 200
aged (195) 195
lipopeptides - pharmacology (186) 186
health aspects (181) 181
mycoses - drug therapy (179) 179
treatment outcome (178) 178
fluconazole - pharmacology (176) 176
in-vitro (175) 175
antifungal agents - administration & dosage (169) 169
fungal proteins - genetics (167) 167
liposomal amphotericin-b (161) 161
albicans (159) 159
candidemia (159) 159
candida-albicans (155) 155
blood-stream infections (153) 153
triazoles - pharmacology (153) 153
echinocandin resistance (151) 151
mutation (149) 149
azoles (146) 146
candida glabrata - drug effects (146) 146
mortality (140) 140
peptides, cyclic - pharmacology (140) 140
antifungal susceptibility (139) 139
aspergillosis (139) 139
fungal-infections (139) 139
infection (139) 139
fungal infections (138) 138
amphotericin b - therapeutic use (136) 136
yeast (136) 136
aspergillosis - drug therapy (135) 135
mice (135) 135
candida albicans (134) 134
drug therapy (134) 134
internal medicine (133) 133
candida - classification (132) 132
therapy (132) 132
drug resistance (131) 131
aspergillus (130) 130
echinocandins - administration & dosage (130) 130
triazoles - therapeutic use (126) 126
analysis (125) 125
drug therapy, combination (125) 125
itraconazole (124) 124
research (123) 123
pharmacokinetics (122) 122
saccharomyces-cerevisiae (122) 122
antifungal agents - pharmacokinetics (117) 117
in-vitro activity (117) 117
immunology (116) 116
peptides, cyclic - therapeutic use (116) 116
antifungal agents - adverse effects (115) 115
polycyclic compounds (115) 115
surveillance (111) 111
microbial sensitivity tests - methods (110) 110
invasive fungal-infections (109) 109
antifungal (108) 108
drug resistance, fungal - genetics (108) 108
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1821) 1821
Spanish (26) 26
French (21) 21
Japanese (15) 15
German (10) 10
Turkish (3) 3
Russian (2) 2
Chinese (1) 1
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Estonian (1) 1
Italian (1) 1
Korean (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 01/2019, Volume 63, Issue 1
Candida auris is an emerging multidrug-resistant yeast that can cause serious invasive infections. The accurate and rapid assessment of antifungal resistance... 
Candida auris | echinocandin | ERG11 | resistance | azole | FKS | molecular beacons | MICROBIOLOGY | PHARMACOLOGY & PHARMACY
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2013, Volume 56, Issue 12, pp. 1724 - 1732
Background. Fluconazole (FLC) resistance is common in C. glabrata and echinocandins are often used as first-line therapy. Resistance to echinocandin therapy... 
Antifungals | Azoles | Health outcomes | Microbial sensitivity tests | Mortality | Polyenes | Infections | Candida glabrata | ARTICLES AND COMMENTARIES | Genetic mutation | Blood | susceptibility | micafungin | resistance | echinocandin | CASPOFUNGIN | INFECTIOUS DISEASES | ASPERGILLUS-FUMIGATUS | MICROBIOLOGY | IMMUNOLOGY | CHANGING EPIDEMIOLOGY | IN-VITRO | ANTIFUNGAL AGENTS | 1,3-BETA-D-GLUCAN SYNTHASE | ALBICANS | BLOOD-STREAM INFECTIONS | INVASIVE CANDIDIASIS | Humans | Middle Aged | Child, Preschool | Infant | Male | Candidiasis - microbiology | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Candidiasis - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Child | Drug Resistance, Fungal | Echinocandins - pharmacology | Infant, Newborn | Glucosyltransferases - genetics | Antifungal Agents - pharmacology | Membrane Proteins - genetics | Treatment Outcome | Fungal Proteins - genetics | Mutation - genetics | Adolescent | Echinocandins - therapeutic use | Aged | Candida glabrata - genetics | Candida glabrata - drug effects | Complications and side effects | Drug resistance in microorganisms | Candidiasis | Gene mutations | Echinocandins | Dosage and administration | Genetic aspects | Research | Drug therapy | Risk factors | Fungal infections | Mutation | Drug resistance | Genes | Pesticides | Index Medicus | and Commentaries
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2015, Volume 61, Issue 11, p. S612
Journal Article
PLoS Pathogens, ISSN 1553-7366, 09/2011, Volume 7, Issue 9, pp. e1002257 - e1002257
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 2017, Volume 61, Issue 10
Journal Article